Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Goetz

Showing results (161-170 of 313) with videos related to

Pageof 32
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|April 21, 2011
Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinationsJennifer G Goldman, Darcy Marr, Lili Zhou, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2011
Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementiaBrandon Barton, David Grabli, Bryan Bernard, et al.
Movement Disorders Clinical Practice|November 29, 2016
Independent Spanish Validation of the Unified Dyskinesia Rating ScaleEsther Cubo, Christopher G Goetz, Glenn T Stebbins, et al.
Brain : a Journal of Neurology|February 1, 2014
Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinationsJennifer G Goldman, Glenn T Stebbins, Vy Dinh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 10, 2006
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trialChristopher G Goetz, Philippe Damier, Christine Hicking, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2017
Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeysStéphane Palfi, Liza Leventhal, Christopher G Goetz, et al.
Movement Disorders Clinical Practice|February 13, 2019
Does Added Objective Tremor Monitoring Improve Clinical Outcomes in Essential Tremor Treatment?Padmaja Vittal, Christopher L Pulliam, Christopher G Goetz, et al.
Brain Sciences|March 29, 2023
Genetics of Neurogenic Orthostatic Hypotension in Parkinson's Disease, Results from a Cross-Sectional In Silico StudyGuenson Chevalier, Lucas Udovin, Matilde Otero-Losada, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 3, 2008
Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessmentsChristopher G Goetz, Sue Leurgans, Vanessa K Hinson, et al.
Archives of Neurology|August 11, 2010
A 12-year population-based study of psychosis in Parkinson diseaseElin B Forsaa, Jan Petter Larsen, Tore Wentzel-Larsen, et al.
Pageof 32

Showing results (161-170 of 313) with videos related to

Sort By:
Pageof 32
Movement Disorders : Official Journal of the Movement Disorder Society|April 21, 2011
Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinationsJennifer G Goldman, Darcy Marr, Lili Zhou, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2011
Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementiaBrandon Barton, David Grabli, Bryan Bernard, et al.
Movement Disorders Clinical Practice|November 29, 2016
Independent Spanish Validation of the Unified Dyskinesia Rating ScaleEsther Cubo, Christopher G Goetz, Glenn T Stebbins, et al.
Brain : a Journal of Neurology|February 1, 2014
Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinationsJennifer G Goldman, Glenn T Stebbins, Vy Dinh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 10, 2006
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trialChristopher G Goetz, Philippe Damier, Christine Hicking, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2017
Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeysStéphane Palfi, Liza Leventhal, Christopher G Goetz, et al.
Movement Disorders Clinical Practice|February 13, 2019
Does Added Objective Tremor Monitoring Improve Clinical Outcomes in Essential Tremor Treatment?Padmaja Vittal, Christopher L Pulliam, Christopher G Goetz, et al.
Brain Sciences|March 29, 2023
Genetics of Neurogenic Orthostatic Hypotension in Parkinson's Disease, Results from a Cross-Sectional In Silico StudyGuenson Chevalier, Lucas Udovin, Matilde Otero-Losada, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 3, 2008
Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessmentsChristopher G Goetz, Sue Leurgans, Vanessa K Hinson, et al.
Archives of Neurology|August 11, 2010
A 12-year population-based study of psychosis in Parkinson diseaseElin B Forsaa, Jan Petter Larsen, Tore Wentzel-Larsen, et al.
Pageof 32